ArticlePDF Available

Abstract and Figures

Objectives: It is well known that the carotenoids lutein (L) and zeaxanthin (Z) improve eye health and an accumulating evidence base suggests cognitive benefits as well. The present study investigated underlying neural mechanisms using functional magnetic resonance imaging (fMRI). It was hypothesized that lower L and Z concentrations would be associated with neurobiological inefficiency (i.e., increased activation) during cognitive performance. Methods: Forty-three community-dwelling older adults (mean age=72 years; 58% female; 100% Caucasian) were asked to learn and recall pairs of unrelated words in an fMRI-adapted paradigm. L and Z levels were measured in retina (macular pigment optical density) and serum using validated procedures. Results: Following first-level contrasts of encoding and retrieval trials minus control trials (p<.05, family-wise error corrected, minimum voxel cluster=8), L and Z were found to significantly and negatively relate to blood-oxygen-level-dependent signal in central and parietal operculum cortex, inferior frontal gyrus, supramarginal gyrus, planum polare, frontal and middle temporal gyrus, superior parietal lobule, postcentral gyrus, precentral gyrus, occipital cortex bilaterally, and cerebellar regions. Conclusions: To the authors' knowledge, the present study represents the first attempt to investigate neural mechanisms underlying the relation of L and Z to cognition using fMRI. The observed results suggest that L and Z promote cognitive functioning in old age by enhancing neural efficiency. (JINS, 2016, 22, 1-12).
Content may be subject to copyright.
Journal of the International Neuropsychological Society (2016), 22,112.
Copyright © INS. Published by Cambridge University Press, 2016.
doi:10.1017/S1355617716000850
Relationship of Lutein and Zeaxanthin Levels to Neurocognitive
Functioning: An fMRI Study of Older Adults
Cutter A. Lindbergh,
1
Catherine M. Mewborn,
1
Billy R. Hammond,
1
Lisa M. Renzi-Hammond,
1
Joanne M. Curran-Celentano,
2
AND L. Stephen Miller
1,3
1
Department of Psychology, University of Georgia, Athens, Georgia
2
Department of Molecular, Cellular, and Biomedical Sciences, University of New Hampshire, Kendall Hall, Durham, New Hampshire
3
Bio-Imaging Research Center, Paul D. Coverdell Center, University of Georgia, Athens, Georgia
(RECEIVED April 9, 2016; FINAL REVISION September 7, 2016; ACCEPTED September 12, 2016)
Abstract
Objectives: It is well known that the carotenoids lutein (L) and zeaxanthin (Z) improve eye health and an accumulating
evidence base suggests cognitive benets as well. The present study investigated underlying neural mechanisms using
functional magnetic resonance imaging (fMRI). It was hypothesized that lower L and Z concentrations would be
associated with neurobiological inefciency (i.e., increased activation) during cognitive performance. Methods:
Forty-three community-dwelling older adults (mean age =72 years; 58% female; 100% Caucasian) were asked to learn
and recall pairs of unrelated words in an fMRI-adapted paradigm. L and Z levels were measured in retina (macular
pigment optical density) and serum using validated procedures. Results: Following rst-level contrasts of encoding and
retrieval trials minus control trials (p<.05, family-wise error corrected, minimum voxel cluster =8), L and Z were found
to signicantly and negatively relate to blood-oxygen-level-dependent signal in central and parietal operculum cortex,
inferior frontal gyrus, supramarginal gyrus, planum polare, frontal and middle temporal gyrus, superior parietal lobule,
postcentral gyrus, precentral gyrus, occipital cortex bilaterally, and cerebellar regions. Conclusions: To the authors
knowledge, the present study represents the rst attempt to investigate neural mechanisms underlying the relation of
L and Z to cognition using fMRI. The observed results suggest that L and Z promote cognitive functioning in old age by
enhancing neural efciency. (JINS, 2016, 22,112)
Keywords: Aging, Cognition, Diet, Food, Magnetic resonance imaging, Carotenoids
INTRODUCTION
The xanthophylls lutein (L) and zeaxanthin (Z) are among
600 naturally occurring carotenoids that must be acquired
via diet, predominantly through consumption of green leafy
vegetables and colored fruits. Of the 3040 carotenoids
present in human sera, generally speaking, only L and Z cross
the bloodretina barrier to form macular pigment (Bone,
Landrum, & Tarsis, 1985). L and Z also preferentially
accumulate in brain tissue, including frontal, occipital, and
temporal cortices, as well as the cerebellum and pons,
accounting for 6677% of total brain carotenoid levels (Craft,
Haitema, Garnett, Fitch, & Dorey, 2004; Johnson et al., 2013;
Vishwanathan, Kuchan, Sen, & Johnson, 2014). As isomers
with identical chemical compositions and extremely similar
structures (Krinsky, 2002), L and Z are often administered
together in clinical trials (e.g., Chew et al., 2014) and
their effects are routinely considered conjointly in analyses
(e.g., Vishwanathan, Iannaccone, et al., 2014).
L and Z have demonstrated potential to benet a range
of neurodegenerative disorders, such as age-related macular
degeneration, diabetic retinopathy, dementia, and Hunting-
tons disease (Arnal, Miranda, Barcia, Bosch-Morell, &
Romero, 2010; Binawade & Jagtap, 2013; Chew et al.,
2014; Feart et al., 2016; Scanlon et al., 2015; Wang, Shinto,
Connor, & Quinn, 2008). Results also appear to support a role
of the macular carotenoids, not only in reducing the probability
of age-related disease, but also in preventing many of the
changes that tend to precede those diseases. For instance,
preliminary data suggest a connection between L and Z levels,
measured in serum and in retina, and executive cognitive
functions, verbal uency, attention, logical reasoning,
Correspondence and reprint requests to: L. Stephen Miller, Department
of Psychology, Psychology Building, University of Georgia, Athens,
Georgia 30602. E-mail: lsmiller@uga.edu
1
. http://dx.doi.org/10.1017/S1355617716000850
Downloaded from http:/www.cambridge.org/core. University of Georgia Libraries, on 28 Oct 2016 at 16:07:28, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms
psychomotor speed, perceptual speed, learning, memory,
language, visual-spatial and constructional abilities, and global
cognition (Akbaraly, Faure, Gourlet, Favier, & Beer, 2007;
Feeney et al., 2013; Renzi, Dengler, Puente, Miller, &
Hammond, 2014; Vishwanathan, Iannaccone, et al., 2014).
Dietary intake of green leafy vegetables high in L and Z
buffers older adults from global cognitive decline, as
demonstrated in longitudinal designs (Kang, Ascherio, &
Grodstein, 2005; Morris, Evans, Tangney, Bienias, & Wil-
son, 2006). Although most of the relevant data is cross-sec-
tional, in an exploratory intervention trial in older women,
docosahexaenoic acid and L supplementation were asso-
ciated with improvements in verbal uency, memory, and
learning slope when compared to placebo (Johnson et al.,
2008; although, see Chew et al., 2015). Taken together, there
is promising evidence suggesting that L and Z exert a positive
effect on a range of cognitive outcomes in older adults.
L and Z have traditionally been measured via two primary
methods: serum and retinal levels. Serum levels of L and Z,
which are frequently combined for analyses due to their
chemical and structural correspondence (e.g., Bone,
Landrum, Dixon, Chen, & Llerena, 2000; Olmedilla-Alonso,
Beltran-de-Miguel, Estevez-Santiago, & Cuadrado-Vives,
2014; Vishwanathan, Iannaccone, et al., 2014), are driven by
recent dietary intakes and do not necessarily reect
long-term dietary behavior, unless dietary behavior is stable
in the individuals measured (Beatty, Nolan, Kavanagh, &
ODonovan, 2004). Some studies have found that serum L
and Z levels remain generally constant with advancing age
(e.g., Cardinault et al., 2003) while others have observed
modest increases (e.g., Olmedilla-Alonso et al., 2014) likely
related to corresponding increases in dietary intake (Johnson,
Maras, Rasmussen, & Tucker, 2010). However, serum L and
Z is lower in individuals with mild cognitive impairment
and Alzheimers disease compared to cognitively healthy
individuals (Nolan et al., 2014; Rinaldi et al., 2003). In the
retina, L and Z preferentially accumulate in the macula as
macular pigment (MP), and optical density of the macular
pigment layer (MPOD) can be measured non-invasively
using psychophysical techniques. The most common method
of measuring MPOD, heterochromatic icker photometry,
has been well-validated (Hammond, Wooten, & Smollon,
2005) and may serve as a biomarker of L and Z concentra-
tions in brain tissue (e.g., Vishwanathan, Iannaccone, et al.,
2014; Vishwanathan, Neuringer, Snodderly, Schalch, &
Johnson, 2013). Like serum levels, MPOD appears to be
lower in individuals with cognitive impairment and dementia
(Feeney et al., 2013; Nolan et al., 2014; Renzi et al., 2014;
Vishwanathan, Iannaccone, et al., 2014). Unlike serum
levels, one advantage of MPOD is that it represents a measure
of L and Z already incorporated into central nervous system
tissue and thus may be a better indicator of longer-term
dietary intakes.
Although serum levels of L and Z are positively correlated
with MPOD (typical rvalues are around 0.30; e.g., Renzi,
Hammond, Dengler, & Roberts, 2012), they represent distinct
measures (e.g., Beatty, et al., 2004; Burke, Curran-Celentano, &
Wenzel, 2005). For example, one study assessed both serum
L and Z and MPOD each month for 24 months and found that
MPOD mean and variance were relatively stable, while serum
concentrations were more variable; additionally, variations in
MPOD and serum concentrations were not linearly related
(Nolan et al., 2006). Another study demonstrated that after
discontinuing supplementation of L and Z, serum concentrations
quickly returned to baseline, whereas changes in MPOD
lasted for up to 100 days (Beatty et al., 2004; Hammond et al.,
1997). These ndings are consistent with the interpretation that
serum concentrations of L and Z more closely reect recent or
acutedietary factors, whereas MPOD, which has a slower
biological turnover, reects more stable L and Z levels acquired
over time.
The mechanisms underlying the relation of L and Z to
cognitive functioning remain to be fully elucidated. In light of
ndings suggesting oxidative stress and inammation play
important roles in dementia and cognitive decline more
broadly (Engelhart et al., 2004; Finkel & Holbrook, 2000;
Pappolla et al., 2002; Teunissen et al., 2003), it is possible
that L and Z exert neuroprotective effects via their anti-
oxidant and/or anti-inammatory properties (Johnson, 2012).
More specically, L and Z quench reactive oxygen molecules
to prevent free radical attack (Johnson, 2014) while altering
inammation-related gene expression (Bian et al., 2012),
pro-inammatory factor production (Li et al., 2012), and
inammatory cytokine signaling to buffer neural damage
(Sasaki et al., 2009). Carotenoids may also impact cognition
by enhancing interneuronal communication through facilita-
tion of signaling compound exchange at gap junctions
(i.e., cell-to-cell channels) and by providing structural sup-
port to synaptic membranes (Krinsky, Mayne, & Sies, 2004;
Stahl & Sies, 2001). Studies using animal models have
supported the possibility of such mechanisms, demonstrating
that carotenoid administration reduces neurodegeneration,
ameliorates oxidative stress and inammation, and improves
cholinergic and mitochondrial dysfunction in brain regions
relevant to cognitive aging, such as cerebral cortex and
hippocampi (Arnal et al., 2010; Binawade & Jagtap, 2013;
Kuhad, Sethi, & Chopra, 2008; Muriach et al., 2006;
Nakashima et al., 2009). Importantly, these neuroprotective
actions are associated with improvements in cognitive
performance on tests of learning and memory (Binawade &
Jagtap, 2013; Kuhad et al., 2008; Nakashima et al., 2009).
The present study aimed to further illuminate mechanisms
by which L and Z relate to cognitive functioning in older
adults using functional magnetic resonance imaging (fMRI)
of verbal memory performance. fMRI has demonstrated
sensitivity to changes in neural activation in healthy and
pathologically aging older adults on memory tasks as well as
to the effects of memory-enhancing interventions, including
both drug and antioxidant therapies (e.g., Bookheimer et al.,
2013; Dickerson et al., 2004; Gutchess et al., 2005; Lorenzi
et al., 2011; Saykin et al., 1999). To the authorsknowledge,
this represents the rst investigation in which a neuroimaging
technique was used to provide an in vivo assessment of the
impact of L and Z on brain function.
2C.A. Lindbergh et al.
. http://dx.doi.org/10.1017/S1355617716000850
Downloaded from http:/www.cambridge.org/core. University of Georgia Libraries, on 28 Oct 2016 at 16:07:28, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms
According to the scaffolding theory of aging and cognition
(STAC), cognitive functioning is preserved in the face of
age-related neural insult through an ongoing process of
reorganization of existing neural connections and recruitment
of additional neural circuitry (Park & Reuter-Lorenz, 2009).
Compensatory scaffoldingis considered to be an adaptive,
dynamic process that occurs in response to intrinsic (e.g.,
biological aging) or extrinsic (e.g., task demands) neural
challenges to maintain cognitive performance (Park &
Reuter-Lorenz, 2009). It is reected in neuroimaging studies
as increased bilateral activation and/or overactivation in
certain regions (e.g., prefrontal cortex; e.g., Cabeza et al.,
1997; Cabeza, Anderson, Locantore, & McIntosh, 2002;
Fera et al., 2005; Haung, Polk, Goh, & Park, 2012). The
notion that additional neural activity reects a compensatory
neurocognitive process is supported by reduced hemispheric
asymmetry as the complexity of a given task increases (e.g.,
Banich, 1998; Hillary, Genova, Chiaravalloti, Rypma, &
DeLuca, 2006), while practice on a given task renes neural
networks such that they become less dispersed and more
specic (e.g., Petersen, van Mier, Fiez, & Raichle, 1998).
With respect to verbal memory, neuroimaging ndings
have suggested that age-related cognitive changes, genetic
vulnerability to disease, and early stages of neurodegenera-
tive conditions such as dementia are associated with more
pronounced and bilateral patterns of brain activity, sugges-
tive of increased neurocognitive effort relative to healthy
counterparts (e.g., Bookheimer et al., 2000; Cabeza et al.,
1997; Dickerson & Sperling, 2008).
In the present study, we evaluated whether L and Z levels
are cross-sectionally related to neurobiological efciency in
community-dwelling older adults via promotion of more
honed neural networks and reduced need for compensatory
scaffolding in response to age-related neural deterioration.
MPOD and serum concentrations of L and Z were assessed
alongside performance on a verbal memory task in which
participants were asked to learn and recall word pairs
(Bookheimer et al., 2000). Lower MPOD and serum L and Z
were hypothesized to predict greater compensatory recruit-
ment during memory encoding and retrieval as evidenced by
increased neural activity required to meet task demands (i.e.,
neurobiological inefciency). For memory encoding, this
pattern of activity was anticipated in medial temporal lobe,
supramarginal and angular gyri, precuneus, dorsolateral
and ventrolateral prefrontal cortex, anterior and posterior
cingulate gyrus, Brocas area, cerebellum, and premotor
areas, consistent with regions-of-interest that have demon-
strated involvement in verbal memory in other studies (e.g.,
Binder, Desai, Graves, & Conant, 2009; Bookheimer et al.,
2000; Cabeza & Nyberg, 2000; Clément & Belleville, 2009).
With the exception of the cerebellum, brain activation was
generally expected to be left-lateralized (Binder et al., 2009;
Cabeza & Nyberg, 2000). A similar frontotemporoparietal
network was hypothesized for memory retrieval, although
brain activity was expected to show greater tendency for
right-lateralization and to evidence greater involvement of
anterior prefrontal cortex and medial parieto-occipital areas,
including retrosplenial cortex and cuneus (Cabeza & Nyberg
2000). Behaviorally, greater MPOD and serum L and Z
were expected to predict enhanced cognitive performance
on measures of word recall. Given that serum and retinal
concentrations of L and Z and their isomers have been
positively related in previous studies, we expected that both
measures would follow the same general pattern of negative
relation to brain activity and positive relation to behavioral
measures of word recall. However, because serum con-
centrations represent acute L and Z levels and MPOD
represents acquired levels, results were not expected to be
identical in all hypothesized regions-of-interest.
METHOD
Participants
Data for the present study were derived from a larger inter-
vention study evaluating the relationship between cognition
and diet in community-dwelling older adults (6586 years)
recruited from the surrounding area via advertisements,
yers, and electronic media (e.g., listservs). Exclusion
criteria included left-handedness, traumatic brain injury, age-
related macular degeneration in either eye, gastric conditions
with potential to interfere with L/Z absorption (gastric ulcer,
gastric band or bypass, Crohns disease, ulcerative colitis),
corrected visual acuity poorer than 20:40, MRI incompat-
ibility, and/or evidence of dementia or other neurological
disorder. Of the participants who were eligible for inclusion
and for which neuroimaging, serum, and MPOD data were
collected (N=50), 6 were unable to complete the MRI
process (e.g., physical discomfort, fatigue, or obvious failure
to follow task instructions) and behavioral data from one
individual were lost due to technical malfunction, leaving
a sample size of 43 for nal analyses. Participants were
compensated $100 for their time and effort. The study was
approved by the University of Georgia Institutional Review
Board for safety and ethical treatment of participants, and the
tenets of the Declaration of Helsinki were adhered to at all
times by all study personnel.
Measures
Wechsler test of adult reading
The Wechsler Test of Adult Reading (WTAR; The
Psychological Corporation, 2001) was administered to
estimate premorbid intellectual functioning (Wechsler,
2001). The WTAR provides a Full-Scale Intelligence
Quotient (FSIQ) estimate based on an algorithm that
incorporates an examinees ability to pronounce a list of
words as well as demographic (i.e., age, education, race, sex,
and geographic region) variables.
Geriatric depression scale
Depressive symptomatology was assessed using the Geriatric
Depression Scale (GDS; Yesavage et al., 1983). The GDS is a
Lutein and zeaxanthin on older adults 3
. http://dx.doi.org/10.1017/S1355617716000850
Downloaded from http:/www.cambridge.org/core. University of Georgia Libraries, on 28 Oct 2016 at 16:07:28, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms
self-report instrument comprised of 30 items of yes/no format
and is scored on a 030 scale, with higher scores indicating
greater levels of depression.
Serum lutein and zeaxanthin
Details of serum analysis can be found elsewhere
(Handelman, Shen, & Krinsky, 1992; Qin et al., 2008).
Briey, a total of 7 mL of whole blood was collected via
venipuncture by a certied phlebotomist. After collection,
samples were immediately placed on ice and centrifuged cold
for 15 min. Following centrifugation, serum was collected
and aliquoted into 1-mL cryotubes and frozen at 80°C for
analysis.
Frozen serum aliquots were thawed to a temperature of
23°C, and precipitated with ethanol. The fat soluble car-
otenoids were extracted from the aqueous suspension with
n-hexane/chloroform. After centrifugation, an aliquot of the
organic phase was evaporated to dryness, re-dissolved in
mobile phase and prepared for injection using an autoinjec-
tion system. L/Z was analyzed using a Hewlett Packard/
Agilent Technologies 1100 series high performance liquid
chromatography (HPLC) system with a photodiode array
detector (Agilent Technologies, Palo Alto, CA). A 5 μm, 200
A° polymeric C
30
reverse-phase column (Pronto-SIL,
MAC-MOD Analytical Inc., Chadds Ford, PA) was used to
separate the analytes.
The HPLC mobile phase solvent A consists of methanol/
tert-butyl methyl ether/water (83:15:2, v/v/v, with 1.5%
ammonium acetate in the water) and solvent B is methanol/
tert-butyl methyl ether/water (8:90:2, v/v/v, with 1%
ammonium acetate in the water). The gradient procedure at a
ow rate of 1 mL/min begins at 100% Solvent A for 2min to
70% Solvent A over a 6-min linear gradient and held at 70%
A for 3 min, then a 10-min linear gradient to 45% Solvent A
and a 2-min hold at 45% Solvent A, then a 10-min linear
gradient to 5% Solvent A, a 4-min hold at 5% Solvent A and,
nally, a 2-min linear gradient back to 100% Solvent A. The
system is held at 100% Solvent A for 10 min for equilibration
back to initial conditions (Qin et al., 2008).
Serum L and Z were analyzed separately via HPLC. To
obtain a combined serum L+Z value, serum L levels (μmol/L)
were added to serum Z levels (μmol/L). The combined L+Z
value was used in all subsequent analyses. To assess the daily
and long-term laboratory performance of the HPLC plasma
analytics, dedicated control plasma was used following
standardization with SRM 968 c (Standard Reference
Materials, National Institute of Standards and Technology,
Gaithersburg, MD).
Macular pigment optical density
Macular pigment optical density (MPOD) was evaluated
using customized heterochromatic icker photometry, as
described previously (Stringham et al., 2008). Briey, a
macular densitometer (Macular Metrics; Rehoboth, MA) was
used to present participants with a 1° visual stimulus that
consisted of two narrow-band LED-based light sources,
peaking at 460 nm and 570 nm. The light sources were
presented in square-wave, counter-phase orientation to present
the appearance of icker. Before measurement, each
participants critical icker fusion frequency was measured
using only the mid-wave portion of the stimulus, so that the
task could be customized to the individual viewer. Following
determination of customized icker sensitivity, participants
were asked to xate on a black dot displayed at the diskscore.
The radiance of the lower (i.e., 460 nm) waveband was
manipulated relative to the 570 nm component to assess the
point at which ickering was no longer perceivable. This
sequence was again conducted with a 2° target and xation
point at 7° nasally to allow a reference measurement in the
parafovea (where MPOD approaches zero). The two loci
(i.e., 30 min, derived from the target, and of retinal
eccentricity) were then compared to provide the MPOD
measurement at 30 min of retinal eccentricity.
Neuroimaging
fMRI task
Participants completed a block design verbal learning task
involving unrelated word pairs (e.g., UPand FOOT)
conceptually based on the Wechsler Memory Scale Verbal
Paired Associates (Wechsler, 2009) and similar to previous
fMRI paradigms (e.g., Bookheimer et al., 2000, 2013;
Braskie, Small, & Bookheimer, 2009). The task was pro-
grammed using E-Prime software (version 1.2, Psychology
Software Tools, Inc., Pittsburgh, PA) and presented through
MRI compatible goggles (Resonance Technology Inc.,
Northridge, CA). Participants responded using a pair of
2-button Cedrus Lumina LU400 MRI compatible response
pads (Cedrus, San Pedro, CA). The task consisted of
10 separate learning blocks, control blocks, retrieval
blocks, and xation blocks, presented sequentially in the
aforementioned order (i.e., learning, control, retrieval,
xation) for every participant (see Figure 1).
In the learning blocks, the rst word of each pair was
presented alone on the left side of the screen (1 s) followed by
presentation of the second word on the right side of the
screen, such that both words were viewable simultaneously
(2 s). There were a total of 10 word pairs, 5 of which were
presented in each encoding block. Participants were instruc-
ted to respond with their right index nger whenever the
second word in the pair appeared, to help verify attention
during learning. During the retrieval portion of the task,
participants were presented with the rst word in each pair
(3 s) and asked to mentally recall (to avoid head motion) the
second word, consistent with procedures used in similar
fMRI-adapted verbal learning paradigms (e.g., Bookheimer
et al., 2000, 2013). Participants were instructed to respond
with their right index nger if they remembered the second
word or to respond with their left index nger if they did not
(maximum score: 50).
Learning and retrieval blocks were interspersed with a
control task analogous to the learning block except that
4C.A. Lindbergh et al.
. http://dx.doi.org/10.1017/S1355617716000850
Downloaded from http:/www.cambridge.org/core. University of Georgia Libraries, on 28 Oct 2016 at 16:07:28, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms
Xs (i.e., XXXXX) and Ys (i.e., YYYYY) were presented
instead of word pairs. Participants responded with their right
index nger whenever the Ys appeared on the screen.
Fixation blocks consisted of a crosshair presented for 6 s.
Immediately following the scan, participants were asked to
engage in free recall (maximum score: 10) followed by cued
recall (maximum score: 10) of the second wordin each pair
to help verify task engagement within the scanner.
MRI acquisition
A General Electric (GE; Waukesha, WI) 3 Tesla Signa HDx
MRI system was used to acquire all scans. Structural scans
were collected using a high-resolution three-dimensional
T
1
-weighted fast spoiled gradient recall echo sequence
[repetition time (TR) =7.5 ms; echo time (TE) =<5 ms;
eld of view (FOV) =256 × 256 mm matrix; ip angle =
20°; slice thickness =1 mm; 154 axial slices; voxel size =
0.94 × 0.94 × 1 mm] with a total acquisition time of 6 min,
20 s. This protocol covered the top of the head to the
brainstem and collected 176 images.
Functional scans were aligned to the anterior commissure-
posterior commissure line and collected axially using a
T
2
*-weighted single shot echo planar imaging (EPI) sequence
(TR =1500 ms; TE =25 ms; 90° RF pulse; acquisition
matrix =64 × 64; FOV =220 × 220 mm; in-plane resolution,
220 × 64 mm; slice thickness =4 mm; 30 interleaved axial
slices; voxel size =3.43 × 3.43 × 4 mm) with an acquisition
time of 12min, 24 s. The EPI sequence covered the cortical
surface and a portion of the cerebellum, and consisted of
290 volumes. A pair of magnitude and phase images was
acquired, lasting 1 min, 40 s each, for eldmap-based unwarping
(TR =700 ms; TE =5.0/7.2 ms; FOV =220 × 220 mm matrix;
ip angle =30°; slice thickness =2 mm; 60 interleaved slices;
voxel size =1.72×1.72×2mm).
Data analysis
Statistical Parametric Mapping (SPM12, Wellcome Depart-
ment of Cognitive Neurology, London, UK) was used to
process and analyze the data. Data were rst converted from
GE DICOM to NIFTI format with the dcm2nii conversion tool
(Rorden, 2007). Preprocessing of functional data included slice
time correction to adjust for the non-sequential, interleaved
acquisition and realignment of functional images to the rst
image of the functional scan to correct for head movement.
Fieldmaps were created to realign and unwarp images to
account for phase and magnitude variations during the scan.
Anatomical scans were co-registered to the rst image of the
functional scan followed by registration of anatomical and
functional imagesto the Montreal Neurological Institute (MNI)
template. The anatomical image was segmented to differentiate
brain tissue (i.e., white matter and gray matter), cerebrospinal
uid, bone, non-brain soft tissue, and air. Deformation elds
were created and applied to functional images to allow spatial
normalization to MNI space. Finally, images were smoothed
using a 6.75-mm FWHM Gaussian lter.
Following pre-processing, activation maps of encoding
minus control task and retrieval minus control task were
created using the General Linear Model (SPM12b). All trials
were included in analyses, regardless of occasional failure to
respond or self-perceived recall success. A statistical threshold
of p<.05, family-wise-error (FWE) corrected, and a minimum
of eight contiguous voxels were selected given optimal balance
between Type I and Type II error rates (Lazar, 2008).
Regression-based analyses were conducted to determine the
relation of L and Z levels to voxel activity within hypothesized
regions-of-interest during memory encoding and recall.
The relation of L and Z levels to behavioral measures of
recall was also evaluated using regression analyses. More
specically, the number of self-reported successful retrievals
across the entire task and on the nal 10 retrieval trials only
(the assumed point of maximal learning), as well as the
number of veried cued successful retrievals measured
immediately post-scan, were considered as dependent
variables in three separate regressions.
Procedure
Following recruitment and screening for exclusion criteria
(described above), data were collected across three testing
Fig. 1. Verbal Learning Task. The above gure provides a visual schematic of the progression of the verbal learning task. The four
blocks (i.e., learning, control, retrieval, and xation) were presented a total of 10 times, resulting in a total acquisition time of 12 min, 24 s.
Five different words pairs were presented in each learning block and 5 sets of XXXXX YYYYY pairings were presented in each control
block. During each retrieval block, participants were asked to recall the second word for ve different word pairs.
Lutein and zeaxanthin on older adults 5
. http://dx.doi.org/10.1017/S1355617716000850
Downloaded from http:/www.cambridge.org/core. University of Georgia Libraries, on 28 Oct 2016 at 16:07:28, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms
sessions. During the rst session, written informed consent
was obtained and MPOD was measured. Participants com-
pleted the GDS and WTAR in the second session, as well
as a handful of other measures that were part of the larger
intervention study and not a focus of the present analyses.
The third session was conducted at the University of Georgia
Bio-Imaging Research Center, which houses the MRI
scanner. Before being placed in the MRI environment,
participants practiced an abbreviated version of the verbal
learning task on a desktop computer to ensure understanding
of task directions and provide the opportunity to ask
questions. The MRI protocol included structural imaging
rst, followed by collection of phase and magnitude images,
and nally acquisition of functional data during the verbal
learning task. Participants were debriefed and thanked at the
end of the testing session.
RESULTS
Sample Characteristics and Verbal Learning
Behavioral Responses
Serum L+Z levels, MPOD, and demographic information
including age, years of formal education, gender and racial
composition, and estimated intellectual functioning are
presented in Table 1. It is notable that the sample was entirely
Caucasian and tended to be well educated.
Table 1 also provides descriptive statistics related to
behavioral performance on the verbal learning task. While in
the scanner, participants, on average, self-reported recall of
the second word in the pair on 37 of the 50 total recall trials
(74%). The group average self-reported (within scanner)
recall during the last two recall blocks only (the assumed point
of maximal learning) was 9 of the 10 total word pairs (90%).
As expected, self-reported recall within the scanner
signicantly correlated with actual cued recall immediately
following the scan (r=0.45; p=.002), differing from each
other by less than two words, on average (mean difference =
1.67; SD =2.00, 3 participants with discrepancy >4words).
The observed correlation provides evidence that participants
were engaged in the task and actively attempting to learn and
recall word pairs within the scanner. In addition, discrepancy
scores between within-scanner recall and actual post-scan
recall were unrelated to MPOD (p=.593) or serum L+Z
(p=.073).
Age and education were considered as potential covariates
in analyses but given nonsignicant zero-order bivariate
correlations to MPOD (r=.17; p=.279, and r=.10;
p=.521, respectively), serum L+Z (r=.02; p=.926, and
r=.07; p=.681, respectively), and behavioral measures of
verbal learning, they were not included in the regression
models.
Whole-Brain Analyses
Using a FWE corrected p<.05 and minimum of eight con-
tiguous voxels, the encoding minus control contrast revealed
widespread activation in regions commonly associated with
verbal learning task performance, including left inferior
frontal regions (Brocas area), middle frontal gyri, hippo-
campus, precentral gyrus, and occipital lobe (see Figure 2).
The recall minus control contrast similarly revealed diffuse
activation in several regions including paracingulate gyri,
insular cortex, middle frontal gyrus, and occipital lobe
(see Figure 3).
Lutein and Zeaxanthin Levels and fMRI
Performance
Behavioral
Serum L+Z and MPOD were unrelated to overt within-
scanner behavioral performance on the verbal learning task.
More specically, MPOD was not a signicant predictor of
the number of self-reported successful retrievals across the
entire paradigm (r=.001; p=.993) nor across the last
10 trials only (i.e., the nal block; r=.103; p=.511).
Similarly, serum L+Z concentrations were not signicantly
related to word retrieval across the entire paradigm (r=.236;
p=.127) nor on the nal block (r=.275; p=.074). MPOD
and serum L+Z levels also displayed nonsignicant relations
to actual cued recall post-scan (r=.137; p=.380, and
r=.084; p=.591, respectively).
Functional imaging
Following the encoding minus control contrast (p<.05,
FWE, minimal voxel cluster =8), regression-based
analyses of blood-oxygen-level-dependent BOLD) signal
Table 1. Descriptive statistics (N=43)
Variable % or M(SD)
Demographics
Age (years) 71.55 (5.84)
Sex (% female) 58.14%
Race (% Caucasian) 100%
Education (years) 16.66 (3.51)
GDS 2.79 (3.20)
Predicted FSIQ
a
115.26 (7.49)
Verbal learning
Total recall (max =50) 36.84 (9.10)
Final block (max =10) 9.00 (1.33)
Post-scan cued recall (max =10) 7.33 (2.21)
Lutein and zeaxanthin
MPOD (o.d.) 0.51 (0.18)
Serum (umol/L) 0.31 (0.17)
Note. o.d. represents the log ratio of transmitted light passing through the
macula.
GDS =Geriatric Depression Scale; FSIQ =Full-Scale Intelligence Quo-
tient from the Wechsler Test of Adult Reading; MPOD =macular pigment
optical density; o.d. =optical density.
a
Data only available for 42 participants.
6C.A. Lindbergh et al.
. http://dx.doi.org/10.1017/S1355617716000850
Downloaded from http:/www.cambridge.org/core. University of Georgia Libraries, on 28 Oct 2016 at 16:07:28, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms
demonstrated that lower MPOD levels were associated with
signicantly greater brain activity (i.e., neural inefciency) in
several regions relevant to verbal learning including left
insular cortex, right middle temporal gyrus, left supramar-
ginal gyrus, and left cerebellum (p<.01; see Table 2 and
Figure 2). With respect to the recall minus control contrast
(p<.05; FWE, minimal voxel cluster =8), lower MPOD
was associated with increased activation in left inferior
frontal gyrus, left insular cortex, left planum polare, right
middle frontal gyrus, left cerebellum, and left and right
occipital pole (p<.01; see Table 3 and Figure 3). As
indicated in Tables 2 and 3, effect sizes for MPOD during
encoding and retrieval ranged from r=.36 to r=.46.
L+Z concentrations in serum similarly demonstrated a
negative relationship with BOLD signal in several brain
regions during encoding including left parietal operculum,
occipital cortex bilaterally (superior division), left postcentral
gyrus, and left precentral gyrus (p<.01; see Table 2 and
Figure 2). During recall, less L+Z in serum was associated
with increased activation in left central opercular cortex, left
superior parietal lobule, and left lateral occipital cortex
(p<.01; see Table 3 and Figure 3). As represented in
Tables 2 and 3, effect sizes for L+Z in serum during encoding
and retrieval ranged from r=.37 to r=.49.
DISCUSSION
L and Z are two carotenoids previously shown to accumulate
in human brain tissue, improve cognitive functioning, and
reduce risk of age-related degenerative diseases (e.g.,
Akbaraly et al., 2007; Johnson, 2014; Johnson et al., 2013;
Nolan et al., 2014; Rinaldi et al., 2003; Vishwanathan,
Iannaccone, et al., 2014). To date, no studies have investi-
gated the neural mechanisms underlying these relationships.
This study sought to determine whether L + Z are related to
neural efciency during a verbal learning and memory task.
Initial whole brain analyses revealed diffuse activation in
regions commonly associated with verbal learning and
retrieval, replicating previous ndings (e.g., Bookheimer
et al., 2000; Cabeza et al., 1997; Dickerson & Sperling,
2008). As expected, lower levels of both MPOD and serum
L+Z concentrations were associated with increased activation
(i.e., neural inefciency) in several of these regions, though
results were not identical for the two measures. Overall,
serum concentrations predicted activity in regions commonly
involved in somatosensory functions (e.g., postcentral gyrus,
parietal and central operculum, superior parietal lobule;
Eickhoff et al., 2010; Molholm et al., 2006), whereas MPOD
was associated with activity in regions more involved in
Fig. 2. Panel (a) depicts whole-brain analyses of the encoding minus control contrast (independent of lutein and zeaxanthin levels)
superimposed on a single-subject anatomical template in MNI space provided by MRIcron (http://www.mricro.com/mricron/install.html).
To conserve space, only six slices were selected for visualization based on largest extent activation and thus not all voxel activity is
represented. Panel (b) displays brain activation signicantly related to lutein and zeaxanthin concentrations during encoding. Areas in
green represent increased activation associated with lower MPOD levels, while areas in red represent increased activation associated with
lower serum lutein and zeaxanthin. Only six slices were selected based on largest extent activation to showcase the relation of lutein and
zeaxanthin to brain activity and thus not every signicant cluster is displayed.
Lutein and zeaxanthin on older adults 7
. http://dx.doi.org/10.1017/S1355617716000850
Downloaded from http:/www.cambridge.org/core. University of Georgia Libraries, on 28 Oct 2016 at 16:07:28, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms
language processing (e.g., inferior frontal gyrus, middle
temporal gyrus, supramarginal gyrus, planum polare; Cabeza
& Nyberg, 2000; Costafreda et al., 2006; Friederici, Meyer,
& von Cramon, 2000). This pattern suggests that acute intake
of L+Z, as represented by serum concentrations, may
boost performance by aiding in somatosensory processing.
Carotenoid consumption over longer periods of time, as
represented by MPOD, may increase performance via more
efcient higher-order language skills.
Regardless of the specic cognitive functions implicated,
pathological aging and cognitive declineinlatelifehavebeen
associated with dysfunction in many of the brain regions
that demonstrated a functional relationship to L+Z levels,
including left inferior frontal gyrus (Bookheimer et al., 2000;
Clément & Bellville, 2009), insula (Xie et al., 2012), middle
temporal gyrus (Convit et al., 2000), middle frontal gyrus
(Rajah, Languay, & Grady, 2011), and central and parietal
operculum (Trachtenberg et al., 2012). The present results
are, therefore, consistent with past studies concluding that a
diet rich in L+Z may buffer pathobiological processes in old
age by enhancing neural efciency in structures at risk for
deterioration.
Both MPOD and serum L+Z levels was associated with
neural efciency in primary visual areas, suggesting that
these carotenoids more generally improve visual processing
(as shown behaviorally; Renzi & Hammond, 2010) beyond
the level of the retina. This nding holds particular relevance
among older adults, who exhibit a high prevalence of visual
difculties due to conditions such as macular degeneration,
which in turn have been shown to impact functional
properties at a neural level (e.g., Baker, Peli, Knouf, &
Kanwisher, 2005).
Contrary to expectation, (serum or MP) L and Z did not
predict behavioral performance on the verbal memory task.
In many respects, however, this observation is consistent
with the STAC in the sense that individuals with lower L and
Z levels were required to recruit additional neural resources
to maintain a similar level of cognitive performance as peers
with higher L and Z levels (Park & Reuter-Lorenz, 2009).
It is also possible that there was a ceiling effect given the
generally high level of cognitive functioning apparent within
the present sample and that a more sensitive cognitive
measure with greater variability in scores would reveal a
relationship. Despite signicant correlations with actual
cued recall post-scan, the reliance on self-reported cognitive
performance within the scanner limited conclusions regard-
ing task accuracy and may have inuenced the observed
results.
Fig. 3. Panel (a) depicts whole-brain analyses of the recall minus control contrast (independent of lutein and zeaxanthin levels)
superimposed on a single-subject anatomical template in MNI space provided by MRIcron (http://www.mricro.com/mricron/install.html).
To conserve space, only six slices were selected for visualization based on largest extent activation and thus not all signicant voxel
activity is represented. Panel (b) displays brain activation signicantly related to lutein and zeaxanthin concentrations during retrieval.
Areas in green represent increased activation associated with lower MPOD levels, while areas in red represent increased activation
associated with lower serum lutein and zeaxanthin. Only six slices were selected based on largest extent activation to showcase the relation
of lutein and zeaxanthin to brain activity and thus not every signicant cluster is displayed.
8C.A. Lindbergh et al.
. http://dx.doi.org/10.1017/S1355617716000850
Downloaded from http:/www.cambridge.org/core. University of Georgia Libraries, on 28 Oct 2016 at 16:07:28, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms
Another important limitation of the present study is its
cross-sectional design, which prevents conclusions regarding
the directionality of the observed relationship between L+Z
and neural efciency. Although longitudinal studies have
indicated that carotenoid consumption preserves neurocog-
nitive health (Min & Min, 2014), other dietary factors
(e.g., antioxidant-rich fruits) left uncontrolled in the present
analyses have been shown to impact brain function as
measured with fMRI (Bookheimer et al., 2013) and the
results should be interpreted with this in mind. For example,
it is possible that L and Z levels serve as proxies for other
features of a healthful diet that relate to brain health, such
as omega-3 fatty acid intake (Witte et al., 2014), and
randomized controlled trials will be required to better
address issues of causality while isolating the effects of the
xanthophylls on neural activity.
Additionally, our sample was entirely Caucasian, highly
educated, and, generally, very cognitively healthy. Thus, the
generalizability of our ndings to individuals characterized
by greater diversity in socioeconomic status, racial back-
ground, and cognitive function may be limited and represents
a critical avenue for future research. Finally, despite the
strong chemical and structural similarities between L and Z,
future neuroimaging studies may benet from considering
their unique effects in analyses rather than combining them as
we have in the present investigation.
To our knowledge, this is the rst study to investigate the
association of L and Z to cognition using fMRI. Results
indicate that L and Z concentrations, measured both acutely
(serum) and acquired (retinal), enhance neural efciency
during verbal learning and memory in older adults. Our
ndings also offer a possible neural mechanism underlying
previous ndings showing a positive relation between
these carotenoids and performance on cognitive tasks (e.g.,
Feeney et al., 2013; Johnson, 2014; Renzi et al., 2014;
Vishwanathan, Iannaccone, et al., 2014). More broadly, the
present study adds to the paucity of research investigating the
critical relationship between diet and brain health, while
identifying a modiable lifestyle factor that may serve to
promote neurocognitive functioning in the rapidly expanding
older adult population.
ACKNOWLEDGMENTS
This research project was funded in part by Abbott Nutritional
Products (Columbus, OH; research grant to B.R.H., L.M.R.,
L.S.M.) and the University of Georgias Bio-Imaging Research
Center (administrative support, L.S.M.). DSM Nutritional Products
(Switzerland) provided the supplements and placebos for the larger
intervention study from which the data for the present study were
derived. Additionally, L.M.R. was an employee of Abbott Nutrition
during a portion of the grant period while holding a joint
appointment at the University of Georgia. B.R.H. has consulted for
Abbott Nutrition. No other potential conicts of interest exist for
any of the study authors, including C.A.L., C.M.M., and J.M.C.
All statistical analyses were completed independently of supporting
agencies.
Table 2. Relationship of lutein and zeaxanthin to brain activation
during encoding (N=43)
Region xyzExtent
Z-
Score
Effect
Size (r)
MPOD
L insular cortex 40 10 14 99 3.03 0.45
L insular cortex 42 0 10 * 2.94 0.44
R middle temporal
gyrus
62 58 2 10 2.75 0.41
L cerebellum 10 76 22 11 2.52 0.38
L supramarginal
gyrus
64 34 26 3 2.44 0.37
Serum
L lateral occipital
cortex
24 74 38 45 2.96 0.44
L postcentral gyrus 20 44 66 31 2.90 0.43
L parietal operculum
cortex
48 30 24 39 2.90 0.43
L precentral gyrus 58 0 32 5 2.76 0.41
R lateral occipital
cortex
36 68 50 17 2.60 0.39
R lateral occipital
cortex
26 78 28 7 2.48 0.37
Note. The above table includes brain activity that was signicantly and
negatively associated with lutein and zeaxanthin levels during encoding
of word pairs.
MPOD =macular pigment optical density. x,y, and zcoordinates are in MNI
space (mm). L =left and R =right.
*=cluster overlap with preceding row.
Table 3. Relationship of lutein and zeaxanthin to brain activation
during recall (N=43)
Region xyzExtent
Z-
Score
Effect
size (r)
MPOD
L inferior frontal
gyrus
42 8 24 48 3.10 0.46
L cerebellum 10 74 22 24 2.96 0.44
L occipital pole 12 102 2 9 2.78 0.41
L planum polare 46 46 8 2.56 0.38
L insular cortex 38 412 15 2.53 0.38
R middle frontal
gyrus
46 34 18 7 2.47 0.37
R occipital pole 16 96 12 2 2.40 0.36
Serum
L central opercular
cortex
48 4 10 21 3.36 0.49
R lateral occipital
cortex
22 68 58 9 2.56 0.38
L central opercular
cortex
58 2 2 7 2.48 0.37
L superior parietal
lobule
38 42 60 4 2.45 0.37
Note. The above table includes brain activity that was signicantly and
negatively associated with lutein and zeaxanthin levels during retrieval
of word pairs. x,y, and zcoordinates are in MNI space (mm).
MPOD =macular pigment optical density. L =left and R =right.
Lutein and zeaxanthin on older adults 9
. http://dx.doi.org/10.1017/S1355617716000850
Downloaded from http:/www.cambridge.org/core. University of Georgia Libraries, on 28 Oct 2016 at 16:07:28, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms
REFERENCES
Akbaraly, N., Faure, H., Gourlet, V., Favier, A., & Berr, C. (2007).
Plasma carotenoid levels and cognitive performance in an elderly
population: Results of the EVA study. Journals of Gerontology,
Series A, Biological Sciences and Medical Sciences,62(3),
308316.
Arnal, E., Miranda, M., Barcia, J., Bosch-Morell, F., & Romero, F.
(2010). Lutein and docosahexaenoic acid prevent cortex lipid
peroxidation in streptozotocin-induced diabetic rat cerebral
cortex. Journal of Neuroscience,166(1), 271278.
Baker, C., Peli, E., Knouf, N., & Kanwisher, N. (2005).
Reorganization of visual processing in macular degeneration.
Journal of Neuroscience,25(3), 614618.
Banich, M. (1998). The missing link: The role of interhemispheric
interaction in attentional processing. Brain and Cognition,36(2),
128157.
Beatty, S., Nolan, J., Kavanagh, H., & ODonovan, O. (2004).
Macular pigment optical density and its relationship with serum
and dietary levels of lutein and zeaxanthin. Archives of
Biochemistry and Biophysics,430,7076.
Bian, Q., Gao, S., Zhou, J., Qin, J., Taylor, A., Johnson, E.,
Shang, F. (2012). Lutein and zeaxanthin supplementation reduces
photooxidative damage and modulates the expression of
inammation-related genes in retinal pigment epithelial cells.
Free Radical Biology and Medicine,53(6), 12981307.
Binawade, Y., & Jagtap, A. (2013). Neuroprotective effect of lutein
against 3-nitropropionic acidinduced Huntingtons diseaselike
symptoms: Possible behavioral, biochemical, and cellular altera-
tions. Journal of Medicinal Food,16(10), 934943.
Binder, J.R., Desai, R.H., Graves, W.W., & Conant, L.L. (2009).
Where is the semantic system? A critical review and meta-
analysis of 120 functional neuroimaging studies. Cerebral
Cortex,19(12), 27672796.
Bookheimer, S., Renner, B., Ekstrom, A., Li, Z., Henning, S.,
Brown, J., Small, G. (2013). Pomegranate juice augments
memory and fMRI activity in middle-aged and older adults with
mild memory complaints. Evidence-Based Complementary and
Alternative Medicine,2013, 946298.
Bookheimer, S., Strojwas, M., Cohen, M., Saunders, A., Pericak-
Vance, M., Mazziotta, J., & Small, G. (2000). Patterns of brain
activation in people at risk for Alzheimers disease. New England
Journal of Medicine,343(7), 450456.
Bone, R.A., Landrum, J.T., Dixon, Z., Chen, Y., & Llerena, C.M.
(2000). Lutein and zeaxanthin in the eyes, serum and diet of
human subjects. Experimental Eye Research,71(3), 239245.
Bone, R., Landrum, J., & Tarsis, S. (1985). Preliminary identica-
tion of the human macular pigment. Vision Research,25(11),
15311535.
Braskie, M., Small, G., & Bookheimer, S. (2009). Entorhinal cortex
structure and functional MRI response during an associative
verbal memory task. Human Brain Mapping,30(12), 39813992.
Burke, J., Curran-Celentano, J., & Wenzel, A. (2005). Diet and
serum carotenoid concentrations affect macular pigment optical
density in adults 45 years and older. Journal of Nutrition,135(5),
12081214.
Cabeza, R., Anderson, N., Locantore, J., & McIntosh, A. (2002).
Aging gracefully: Compensatory brain activity in high-
performing older adults. Neuroimage,17(3), 13941402.
Cabeza, R., Grady, C., Nyberg, L., McIntosh, A., Tulving, E.,
Kapur, S., Craik, F. (1997). Age-related differences in neural
activity during memory encoding and retrieval: A positron
emission tomography study. Journal of Neuroscience,17(1),
391400.
Cabeza, R., & Nyberg, L. (2000). Imaging Cognition II: An
empirical review of 275 PET and fMRI studies. Journal of
Cognitive Neuroscience,12(1), 147.
Cardinault, N., Gorrand, J., Tyssandier, V., Grolier, P., Rock, E., &
Borel, P. (2003). Short-term supplementation with lutein affects
biomarkers of lutein status similarly in young and elderly
subjects. Experimental Gerontology,38, 573582.
Clément, F., & Belleville, S. (2009). Testretest reliability of fMRI
verbal episodic memory paradigms in healthy older adults and in
persons with mild cognitive impairment. Human Brain Mapping,
30(12), 40334047.
Chew, E., Clemons, T., SanGiovanni, J., Danis, R., Ferris, F.,
Elman, M., Fish, G. (2014). Secondary analyses of the effects
of lutein/zeaxanthin on age-related macular degeneration
progression: AREDS2 Report No. 3. Journal of the American
Medical Association Ophthalmology,132(2), 142149.
Chew, E., Clemons, T., Agrón, E., Launer, L., Grodstein, F., &
Bernstein, P. (2015). Effect of omega-3 fatty acids, lutein/
zeaxanthin, or other nutrient supplementation on cognitive
function: The AREDS2 randomized clinical trial. Journal of the
American Medical Association,314(8), 791801.
Convit, A., de Asis, J., de Leon, M., Tarshish, C., De Santi, S., &
Rusinek, H. (2000). Atrophy of the medial occipitotemporal,
inferior, and middle temporal gyri in non-demented elderly
predict decline to Alzheimers disease. Neurobiology of Aging,
21(1), 1926.
Costafreda, S., Fu, C., Lee, L., Everitt, B., Brammer, M., & David,
A. (2006). A systematic review and quantitative appraisal of
fMRI studies of verbal uency: Role of the left inferior
frontal gyrus. Human Brain Mapping,27(10), 799810.
Craft, N., Haitema, T., Garnett, K., Fitch, K., & Dorey, C. (2004).
Carotenoid, tocopherol, and retinol concentrations in elderly
human brain. Journal of Nutrition Health and Aging,8(3),
156162.
Dickerson, B., Salat, D., Bates, J., Atiya, M., Killiany, R.,
Greve, D., Sperling, R.A. (2004). Medial temporal lobe
function and structure in mild cognitive impairment. Annals of
Neurology,56(1), 2735.
Dickerson, B., & Sperling, R. (2008). Functional abnormalities of
the medial temporal lobe memory system in mild cognitive
impairment and Alzheimers disease: Insights from functional
MRI studies. Neuropsychologia,46(6), 16241635.
Eickhoff, S., Jbabdi, S., Caspers, S., Laird, A., Fox, P., Zilles, K., &
Behrens, T. (2010). Anatomical and functional connectivity of
cytoarchitectonic areas within the human parietal operculum.
Journal of Neuroscience,30(18), 64096421.
Engelhart, M.J., Geerlings, M.I., Meijer, J., Kiliaan, A., Ruitenberg,
A., van Swieten, J.C., Breteler, M.M. (2004). Inammatory
proteins in plasma and the risk of dementia: The Rotterdam
Study. Archives of Neurology,61(5), 668672.
Feart, C., Letenneur, L., Helmer, C., Samieri, C., Schalch, W.,
Etheve, S., Barberger-Gateau, P. (2016). Plasma carotenoids
are inversely associated with dementia risk in an elderly
French cohort. Journals of Gerontology, Series A, Biological
Sciences and Medical Sciences,71(5), 683688.
Feeney, J., Finucane, C., Savva, G.M., Cronin, H., Beatty, S.,
Nolan, J.M., & Kenny, R.A. (2013). Low macular pigment
optical density is associated with lower cognitive performance in
a large, population-based sample of older adults. Neurobiology of
Aging,34(11), 24492456.
10 C.A. Lindbergh et al.
. http://dx.doi.org/10.1017/S1355617716000850
Downloaded from http:/www.cambridge.org/core. University of Georgia Libraries, on 28 Oct 2016 at 16:07:28, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms
Fera, F., Weickert, T.W., Goldberg, T.E., Tessitore, A., Hariri, A.,
Das, S., Mattay, V. (2005). Neural mechanisms underlying
probabilistic category learning in normal aging. Journal of
Neuroscience,25(49), 1134011348.
Finkel, T., & Holbrook, N. (2000). Oxidants, oxidative stress and
the biology of ageing. Nature,408(6809), 239247.
Friederici, A., Meyer, M., & von Cramon, D. (2000). Auditory
language comprehension: An event-related fMRI study on the
processing of syntactic and lexical information. Brain and
Language,74(2), 289300.
Gutchess, A., Welsh, R., Hedden, T., Bangert, A., Minear, M.,
Liu, L., & Park, D. (2005). Aging and the neural correlates of
successful picture encoding: Frontal activations compensate
for decreased medial-temporal activity. Journal of Cognitive
Neuroscience,17(1), 8496.
Hammond, B.R., Johnson, E.J., Russell, R.M., Krinsky, N.,
Yeum, K., Edwards, R., & Snodderly, D. (1997). Dietary
modication of human macular pigment density. Investigative
Opthalmology & Visual Science,38(9), 17951801.
Hammond, B., Wooten, B., & Smollon, B. (2005). Assessment of
the validity of in vivo methods of measuring human macular
pigment optical density. Optometry & Vision Science,82(5),
387404.
Handelman, G.J., Shen, B., & Krinksy, N.I. (1992). High resolution
analysis of carotenoids in human plasma by high-performance
liquid chromatography. Methods in Enzymology,213, 336346.
Hillary, F.G., Genova, H.M., Chiaravalloti, N.D., Rypma, B., &
DeLuca, J. (2006). Prefrontal modulation of working memory
performance in brain injury and disease. Human Brain Mapping,
27(11), 837847.
Huang, C.-M., Polk, T., Goh, J., & Park, D. (2012). Both left and
right posterior parietal activations contribute to compensatory
processes in normal aging. Neuropsychologia,50(1), 5566.
Johnson, E.J. (2012). A possible role for lutein and zeaxanthin in
cognitive function in the elderly. American Journal of Clinical
Nutrition,96(5), 11611165.
Johnson, E. (2014). Role of lutein and zeaxanthin in visual and
cognitive function throughout the lifespan. Nutrition Reviews,
72(9), 605612.
Johnson, E., Maras, J.E., Rasmussen, H.M., & Tucker, K.L. (2010).
Intake of lutein and zeaxanthin differ with age, sex, and ethnicity.
Journal of the American Dietetic Association,110(9),
13571362.
Johnson, E., McDonald, K., Caldarella, S., Chung, H., Troen, A., &
Snodderly, D. (2008). Cognitive ndings of an exploratory trial of
docosahexaenoic acid and lutein supplementation in
older women. Nutritional Neuroscience,11(2), 7583.
Johnson, E.J., Vishwanathan, R., Johnson, M.A., Hausman, D.B.,
Davey, A., Scott, T.M., Poon, L.W. (2013). Relationship
between serum and brain carotenoids, α-tocopherol, and retinol
concentrations and cognitive performance in the oldest old from
the Georgia Centenarian Study. Journal of Aging Research,
2013, 951786.
Kang, J., Ascherio, A., & Grodstein, F. (2005). Fruit and vegetable
consumption and cognitive decline in aging women. Annals of
Neurology,57(5), 713720.
Krinsky, N. (2002). Possible biologic mechanisms for a protective
role of xanthophylls. The Journal of Nutrition,132(3), 540542.
Krinsky, N., Mayne, S., & Sies, H. (2004). Carotenoids in health
and disease. Florida: CRC Press.
Kuhad, A., Sethi, R., & Chopra, K. (2008). Lycopene attenuates
diabetes-associated cognitive decline in rats. Life Sciences,
83(3-4), 128134.
Lazar, N. (2008). The statistical analysis of functional MRI data.
New York: Springer.
Li, S., Fung, F., Fu, Z., Wong, D., Chan, H., & Lo, A. (2012). Anti-
inammatory effects of lutein in retinal ischemic/hypoxic injury:
In vivo and in vitro studies. Investigative Ophthalmology and
Visual Science,53(10), 59765984.
Lorenzi, M.M., Beltramello, A., Mercuri, N.B., Canu, E., Zoccatelli, G.,
Pizzini, F.B., Frisoni, G.B. (2011). Effect of memantine on resting
state default mode network activity in Alzheimers disease. Drugs
and Aging,28(3), 205217.
Min, J., & Min, K. (2014). Serum lycopene, lutein and zeaxanthin,
and the risk of Alzheimers disease mortality in older
adults. Dementia and Geriatric Cognitive Disorders,37(3-4),
246256.
Molholm, S., Sehatpour, P., Mehta, A.D., Shpaner, M., Gomez-
Ramirez, M., Ortigue, S., Foxe, J.J. (2006). Audio-visual
multisensory integration in superior parietal lobule revealed by
human intracranial recordings. Journal of Neurophysiology,
96(2), 721729.
Morris, M.C., Evans, D., Tangney, C., Bienias, J., & Wilson, R.S.
(2006). Associations of vegetable and fruit consumption with
age-related cognitive change. Neurology,67(8), 13701376.
Muriach, M., Bosch-Morell, F., Alexander, G., Blomhoff, R.,
Barcia, J., Arnal, E., Miranda, M. (2006). Lutein effect on
retina and hippocampus of diabetic mice. Free Radical Biology
and Medicine,41(6), 979984.
Nakashima, Y., Ohsawa, I., Konishi, F., Hasegawa, T.,
Kumamoto, S., Suzuki, Y., & Ohta, S. (2009). Preventive effects
of Chlorella on cognitive decline in age-dependent dementia
model mice. Neuroscience Letters,464(3), 193198.
Nolan, J.M., Loskutova, E., Howard, A.N., Moran, R., Mulcahy, R.,
Stack, J., Beatty, S. (2014). Macular pigment, visual function,
and macular disease among subjects with Alzheimers disease:
An exploratory study. Journal of Alzheimers Disease,42(4),
11911202.
Nolan, J.M., Stack, J., Mellerio, J., Godhinio, M., ODonovan, O.,
Neelam, K., & Beatty, S. (2006). Monthly consistency of macular
pigment optical density and serum concentrations of lutein and
zeaxanthin. Current Eye Research,31(2), 199213.
Olmedilla-Alonso, B., Beltrán-de-Miguel, B., Estévez-Santiago, R.,
& Cuadrado-Vives, C. (2014). Markers of lutein and zeaxanthin
status in two age groups of men and women: Dietary intake,
serum concentrations, lipid prole and macular pigment optical
density. Nutrition Journal,13(1), 142160.
Pappolla, M.A., Smith, M.A., Bryant-Thomas, T., Bazan, N.,
Petanceska, S., Perry, G., Refolo, L.M. (2002). Cholesterol,
oxidative stress, and Alzheimers disease: Expanding the
horizons of pathogenesis. Free Radical Biology and Medicine,
33(2), 173181.
Park, D.C., & Reuter-Lorenz, P. (2009). The adaptive brain: Aging
and neurocognitive scaffolding. Annual Review of Psychology,
60, 173196.
Petersen, S.E., Van Mier, H., Fiez, J.A., & Raichle, M.E. (1998).
The effects of practice on the functional anatomy of task
performance. Proceedings of the National Academy of Sciences
of the United States of America,95(3), 853860.
Qin, J.Y., Yeum, K.J., Johnson, E.J., Krinsky, N.I., Russell, R.M., &
Tang, G. (2008). Determination of 9-cis β-carotene and
Lutein and zeaxanthin on older adults 11
. http://dx.doi.org/10.1017/S1355617716000850
Downloaded from http:/www.cambridge.org/core. University of Georgia Libraries, on 28 Oct 2016 at 16:07:28, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms
ζ-carotene in biological samples. Journal of Nutritional Biochemistry,
19(9), 612618.
Rajah, M.N., Languay, R., & Grady, C.L. (2011). Age-related
changes in right middle frontal gyrus volume correlate with
altered episodic retrieval activity. Journal of Neuroscience,
31(49), 1794117954.
Renzi, L., & Hammond, B.R. (2010). The relation between the
macular carotenoids, lutein and zeaxanthin, and temporal vision.
Ophthalmic and Physiological Optics,30(4), 351357.
Renzi, L.M., Hammond, B.R., Dengler, M., & Roberts, R. (2012).
The relation between serum lipids and lutein and zeaxanthin in the
serum and retina: Results from cross-sectional, case-control and
case study designs. Lipids in Health and Disease,11(1), 110.
Renzi, L.M., Dengler, M.J., Puente, A., Miller, L.S., & Hammond, B.R.,
Jr. (2014). Relationships between macular pigment optical density and
cognitive function in unimpaired and mildly cognitively impaired
older adults. Neurobiology of Aging,35(7), 16951699.
Rinaldi, P., Polidori, M., Metastasio, A., Mariani, E., Mattioli, P.,
Cherubini, A., Mecocci, P. (2003). Plasma antioxidants are
similarly depleted in mild cognitive impairment and in
Alzheimers disease. Neurobiology of Aging,24(7), 915919.
Rorden, C. (2007). DCM2NII (Computer software). Retrieved from
https://www.nitrc.org/projects/dcm2nii/
Sasaki, M., Ozawa, Y., Kurihara, T., Noda, K., Imamura, Y.,
Kobayashi, S., Tsubota, K. (2009). Neuroprotective effect of
an antioxidant, lutein, during retinal inammation. Investigative
Opthalmology and Visual Science,50(3), 1433.
Saykin, A.J., Flashman, L.A., Frutiger, S.A., Johnson, S.C.,
Mamourian, A.C., Moritz, C.H., Weaver, J.B. (1999).
Neuroanatomic substrates of semantic memory impairment in
Alzheimers disease: Patterns of functional MRI activation.
Journal of the International Neuropsychological Society,5(5),
377392.
Scanlon, G., Connell, P., Ratzlaff, M., Foerg, B., McCartney, D.,
Murphy, A., Loughman, J. (2015). Macular pigment optical
density is lower in type 2 diabetes, compared with type 1 diabetes
and normal controls. Retina,35(9), 18081816.
Stahl, W., & Sies, H. (2001). Effects of carotenoids and retinoids on
gap junctional communication. Biofactors,15(24), 9598.
Stringham, J.M., Hammond, B.R., Nolan, J.M., Wooten, B.R.,
Mammen, A., Smollon, W., & Snodderly, D.M. (2008). The utility
of using customized heterochromatic icker photometry (cHFP) to
measure macular pigment in patients with age-related macular
degeneration. Experimental Eye Research,87(5), 445453.
Teunissen, C.E., Van Boxtel, M.P.J., Bosma, H., Bosmans, E.,
Delanghe, J., De Bruijn, C., De Vente, J. (2003). Inammation
markers in relation to cognition in a healthy aging population.
Journal of Neuroimmunology,134(1), 142150.
Trachtenberg, A.J., Filippini, N., Ebmeier, K.P., Smith, S.M.,
Karpe, F., & Mackay, C.E. (2012). The effects of APOE on the
functional architecture of the resting brain. Neuroimage,59(1),
565572.
Vishwanathan, R., Iannaccone, A., Scott, T.M., Kritchevsky, S.B.,
Jennings, B.J., Carboni, G., Johnson, E.J. (2014). Macular
pigment optical density is related to cognitive function in
older people. Age and Ageing,43(2), 271275.
Vishwanathan, R., Kuchan, M., Sen, S., & Johnson, E. (2014).
Lutein and preterm infants with decreased concentrations of brain
carotenoids. Journal of Pediatric Gastroenterology and Nutri-
tion,59(5), 659665.
Vishwanathan, R., Neuringer, M., Snodderly, D.M., Schalch, W., &
Johnson, E.J. (2013). Macular lutein and zeaxanthin are related to
brain lutein and zeaxanthin in primates. Nutritional Neu-
roscience,16(1), 2129.
Wechsler, D. (2001). Wechsler Test of Adult Reading: WTAR. San
Antonio, TX: Psychological Corporation.
Wechsler, D. (2009). The Wechsler Memory Scale-Fourth Edition
(WMS-IV). San Antonio, TX: Pearson Assessments.
Wang, W., Shinto, L., Connor, W.E., & Quinn, J.F. (2008).
Nutritional biomarkers in Alzheimers disease: The association
between carotenoids, n-3 fatty acids, and dementia severity.
Journal of Alzheimers Disease,13(1), 3138.
Witte, A.V., Kerti, L., Hermannstädter, H.M., Fiebach, J.B.,
Schreiber, S.J., Schuchardt, J.P., Flöel, A. (2014). Long-
chain omega-3 fatty acids improve brain function and structure in
older adults. Cerebral Cortex,24(11), 30593068.
Xie, C., Bai, F., Yu, H., Shi, Y., Yuan, Y., Chen, G., Li, S.
(2012). Abnormal insula functional network is associated with
episodic memory decline in amnestic mild cognitive impairment.
Neuroimage,63(1), 320327.
Yesavage, J.A., Brink, T.L., Rose, T.L., Lum, O., Huang, V.,
Adey, M., & Leirer, V.O. (1983). Development and validation of
a geriatric depression screening scale: A preliminary report.
Journal of Psychiatric Research,17(1), 3749.
12 C.A. Lindbergh et al.
. http://dx.doi.org/10.1017/S1355617716000850
Downloaded from http:/www.cambridge.org/core. University of Georgia Libraries, on 28 Oct 2016 at 16:07:28, subject to the Cambridge Core terms of use, available at http:/www.cambridge.org/core/terms
... 7 Notably, dietary intake of these compounds, not supplements, tends to have profounder effects. 8 There have been multiple RCTs testing the effects on cognition and neurological health by adding foods particularly rich in phytochemicals, such as berries, which have consistently shown both acute and long-term improvements in cognitive function and reduced neuronal inflammation and pathology. [9][10][11][12][13][14][15][16] The neuroprotective effects of the intake of whole-food nutrients is well-documented. ...
Article
Full-text available
We argue that the provision of substantial dietary modifications to individuals who wish to maximize their brain health is ethically permitted, despite evidence for such an intervention being not yet fully conclusive. However, we argue that for a burdensome therapy with weak evidence and potential harms, balanced communication, informed consent and follow-up are necessary components of the ethical provision of such lifestyle changes. Moreover, health should be discussed as a value with individuals alongside non-health priorities to achieve balance and avoid brain healthism.
... Lutein supplementation enhances cognitive performance in older persons, especially in domains like memory and attention. fMRI studies have demonstrated that lutein has neuroprotective benefits via increasing brain activity and connection [72]. ...
Chapter
Full-text available
Carotenoids are plant-derived compounds that have numerous health benefits, encompassing disease protection, cardiovascular health, mental and physical development, etc. Carotenoids exert their effect by combating oxidative stress, scavenging free radicals and quenching singlet oxidants, hence an effective metabolic antioxidant. Recently, carotenoids have gained a debated interest, wherein research momentum diverges to understand their antioxidant as well as prooxidant functions. Research focuses on investigating the prooxidant function stemming from the ability of carotenoids to induce oxidative damage. Herein, we will discuss the general classification, structure and physiological reactions of carotenoids. The emphasis will lie in understanding the triggers and mechanisms that influence their antioxidant versus prooxidant ability. We aim to outline the likely conditions enabling their antioxidant and/or prooxidant activities. A thorough mechanistic understanding of these highly beneficial nutrients will provide a toolkit for preventing diseases in addition to treating diseases through their exclusive prooxidant abilities.
... It has been well established that a higher level of serum and brain carotenoids is associated with improved cognitive function [114][115][116][117]. It is important to note that the carotenoids present in the macular pigment are also widely present in the brain [118]. ...
Article
Full-text available
Background: Carotenoids are present throughout retina and body its dense deposition leads to an identifiable yellow spot in the macula. Macular pigment optical density (MPOD) measured in the macula is vital to macular well-being and high-resolution visual acuity. MPOD has also been associated with various health and disease states. We sought to review the literature on this topic and summarize MPODs role as a measurable modifiable clinical biomarker, particularly as a measure of the eye’s antioxidant capacity in the context of oxidative damage and retinal ischemia. Methods: A literature review collated the articles relevant to MPOD, carotenoid intake or supplementation, and their influence on various health and disease states. Results: Literature reveals that MPOD can serve as a reliable biomarker for assessing the retinal defense mechanisms against oxidative stress and the deleterious effects of excessive light exposure. Elevated MPOD levels offer robust protection against the onset and progression of age-related macular degeneration (AMD), a prevalent cause of vision impairment among the elderly population. MPOD’s implications in diverse ocular conditions, including diabetic retinopathy and glaucoma, have been explored, underscoring the real need for clinical measurement of MPOD. The integration of MPOD measurement into routine eye examinations presents an unparalleled opportunity for early disease detection, precise treatment planning, and longitudinal disease monitoring. Conclusions: Longitudinal investigations underscore the significance of MPOD in the context of age-related ocular diseases. These studies show promise and elucidate the dynamic nuances of MPOD’s status and importance as a measurable, modifiable clinical biomarker.
... It has been well established that a higher level of serum and brain carotenoids are associated with improved cognitive function [107][108][109][110]. It is important to note that the carotenoids present in the macular pigment are also widely present in the brain [111]. ...
Preprint
Full-text available
The macular pigment optical density (MPOD) signifies a vital component of macular well-being and high-resolution visual acuity. MPOD can serve as a reliable biomarker for assessing the retinal defense mechanisms against oxidative stress and the deleterious effects of excessive light exposure. Elevated MPOD levels offer robust protection against the onset and progression of age-related macular degeneration (AMD) a prevalent cause of vision impairment among the elderly population. MPOD's implications in diverse ocular conditions, including diabetic retinopathy and glaucoma, have been explored and indicate a real need for clinical measurement of MPOD. This review looks at the potential of MPOD as a modifiable biomarker influencing the progression and onset of these conditions, particularly in the context of oxidative stress and retinal ischemia. The integration of MPOD measurement into routine eye examinations presents an unparalleled opportunity for early disease detection, precise treatment planning, and longitudinal disease monitoring. Emerging technologies and longitudinal investigations promise to elucidate the dynamic nuances of MPOD in the context of age-related ocular diseases.
... 8 Moreover, we were able to control for a large number of potential confounders. 379 We used FAMD to derive a continuous indicator of CVD burden, as previous studies have 380 shown increased sensitivity of continuous quantification of small vessel disease compared to 381 simple rating scores. [23][24][25] Different statistical approaches have been proposed and a 382 methodological study should be conducted to formally compare methods. ...
Thesis
Full-text available
La nutrition est un facteur environnemental modifiable prometteur pour la prévention du vieillissement cérébral. Une association bénéfique entre une alimentation plus saine ou des apports plus importants en certains nutriments et un moindre risque de démence ou de déclin cognitif a été suggérée dans les études épidémiologiques. Cependant, la stratégie nutritionnelle à privilégier pour la prévention reste encore mal caractérisée. Mieux décrire les mécanismes neurobiologiques chez l’Homme permettrait d’identifier les stratégies préventives les plus efficaces. L'objectif de cette thèse est d'analyser les associations épidémiologiques entre la nutrition et des marqueurs en neuro-imagerie de deux composantes physiopathologiques clés du vieillissement cérébral : la structure cérébrale et la neurodégénérescence associée d’une part, le fardeau cérébral vasculaire d’autre part. La nutrition est étudiée à travers plusieurs expositions complémentaires, du statut biologique en nutriments candidats jusqu’aux profils de consommation alimentaire. Les données proviennent de l’étude des 3-Cités, une cohorte de personnes âgées issues de la population générale. Dans une première partie, nous nous sommes intéressés à la relation entre nutrition et évolution des volumes cérébraux à l’Imagerie par Résonance Magnétique (IRM) au cours de 10 ans suivi dans la cohorte. Nous avons mis en évidence des associations entre des concentrations plasmatiques plus élevées en acides gras polyinsaturés oméga-3 (AGPI n-3) et en caroténoïdes avec une moindre atrophie du lobe temporal médian, une structure clé pour la mémoire et impliquée dans développement de la maladie d’Alzheimer. Dans une deuxième partie, une approche plus globale de l’alimentation a été adoptée avec l’évaluation de l’adhérence au Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet. Ce régime alimentaire spécifiquement développé pour la santé cérébrale a été associé à un moindre risque de démence sur 16 ans de suivi et à une meilleure intégrité de la substance blanche, dégradée dans le vieillissement cérébral et dans la maladie d’Alzheimer. Dans une dernière partie, nous avons abordé la composante vasculaire de la santé cérébrale et montré une association entre une consommation de poisson plus élevée et un moindre fardeau cérébrovasculaire global, défini par la combinaison de trois marqueurs IRM : hypersignaux de la substance blanche, infarctus cérébraux silencieux et dilatations des espaces périvasculaires. Ces résultats décryptent les effets spécifiques de différentes expositions nutritionnelles sur la santé cérébrale dans le vieillissement, suggérant un rôle prépondérant des AGPI n-3 apportés par le poisson, associés à la fois à une diminution de l’atrophie et du fardeau cérébrovasculaire. Le MIND diet (intégrant le poisson et les légumes colorés, sources de caroténoïdes) était associé à une préservation globale de la microstructure cérébrale et pourrait être une stratégie de prévention efficace d’un point de vue de la santé publique.
Article
Full-text available
Purpose of Review This study is to examine potential micronutrient deficiencies and any need for supplementation in children following specific diet plans in the first 1000 days of life. Recent Findings Optimal nutrition in the first 1000 days of life has a lifelong positive impact on child development. Specific intrauterine and perinatal factors, pathological conditions, and dietary restrictions can represent potential risk factors for micronutrient deficiencies in the first 1000 days of life, which can have negative systemic consequences. Preterm and low-birth-weight infants are intrinsically at risk because of immature body systems. Children affected by cystic fibrosis are prone to malnutrition because of intestinal malabsorption. The risk of micronutrient deficiency can increase in various situations, including but not limited to children following selective dietary regimens (vegetarian and vegan diets and children affected by specific neuropsychiatric conditions) or specific dietary therapies (children affected by food allergies or specific metabolic disorders and children following restricted diet as a part of therapeutic approach, i.e., ketogenic diet for epilepsy). In light of this situation, the micronutrient status in these categories of children should be investigated in order to tailor strategies specific to the individual’s metabolic needs, with a particular focus on deficiencies which can impair or delay the physical and cognitive development of children, namely, vitamin B12, vitamin D and folic acid, as well as oligo-elements such as iron, zinc, calcium, sodium, magnesium, and phosphorus, and essential fatty acids such as omega-3. Summary Identification of micronutrient deficiency in the first 1000 days of life and timely supplementation proves essential to prevent their long-term consequences. Graphical Abstract
Article
Neurological disorders incidences are increasing drastically due to complex pathophysiology, and the nonavailability of disease‐modifying agents. Several attempts have been made to identify new potential chemicals to combat these neurological abnormalities. At present, complete abolishment of neurological diseases is not attainable except for symptomatic relief. However, dietary recommendations to help brain development or improvement have increased over the years. In recent times, cruciferous vegetables and their phytochemicals have been identified from preclinical and clinical investigations as potential neuroprotective agents. The present review highlights the beneficial effects and molecular mechanisms of phytochemicals such as indole‐3‐carbinol, diindolylmethane, sulforaphane, kaempferol, selenium, lutein, zeaxanthin, and vitamins of cruciferous vegetables against neurological diseases including Parkinson's disease, Alzheimer's disease, stroke, Huntington's disease, autism spectra disorders, anxiety, depression, and pain. Most of these cruciferous phytochemicals protect the brain by eliciting antioxidant, anti‐inflammatory, and antiapoptotic properties. Regular dietary intake of cruciferous vegetables may benefit the prevention and treatment of neurological diseases. The present review suggests that there is a lacuna in identifying the clinical efficacy of these phytochemicals. Therefore, high‐quality future studies should firmly establish the efficacy of the above‐mentioned cruciferous phytochemicals in clinical settings.
Article
Full-text available
Although intake of fruits and vegetables has been associated with a decreased risk of dementia, studies focusing on nutrients underlying this association are lacking. Our objective was to analyze the relation between plasma carotenoids and the risk of dementia and Alzheimer's disease (AD) in French elderly community dwellers. The study population consisted of 1,092 nondemented older participants, from the Three-City-Bordeaux cohort followed for up to 10 years (range: 1.8-10.8 years, median: 9.5 years). Dementia and AD were diagnosed by a committee of neurologists. The concentration of plasma carotenoids (beta-carotene, alpha-carotene, lycopene, lutein, zeaxanthin, and beta-cryptoxanthin) was determined at baseline. Longitudinal analyses of the association between each plasma carotenoid, either crude or expressed as a ratio to plasma lipids (total cholesterol + triglycerides), and the risk of dementia or AD were performed by multivariate Cox models. During follow-up, 199 dementia cases, including 132 AD, occurred. After adjustment for sociodemographic data, diet quality, and clinical variables, including baseline cognitive performances, only higher lutein concentration, considered as a function of plasma lipids, was consistently significantly associated with a decreased risk of all-cause dementia and AD (hazard ratio = 0.808, 95% confidence interval = 0.671-0.973, p = .024 and hazard ratio = 0.759, 95% confidence interval = 0.600-0.960, p = .021, respectively for +1 SD). This large cohort of older participants suggests that maintaining higher concentrations of lutein in respect to plasma lipids may moderately decrease the risk of dementia and AD. © The Author 2015. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Article
Full-text available
This study was designed to investigate the optical density of macular pigment in Type 1 and Type 2 diabetes subjects relative to normal controls. One hundred and fifty subjects were recruited to the study and divided into one of the three study groups on the basis of their health status, as follows: Group 1: Healthy controls; Group 2: Type 1 diabetes; Group 3: Type 2 diabetes. Macular Pigment Optical Density, at 0.5° of retinal eccentricity, was measured using customized heterochromatic flicker photometry. Dietary intake of macular carotenoids was quantified using a lutein and zeaxanthin food frequency questionnaire. Diabetes type, duration, medication, smoking habits, glycosylated hemoglobin (HbA1C), and serum lipid levels were recorded, whereas visual acuity, body mass index, and diabetic retinopathy grade were measured for each participant. One-way analysis of variance revealed a statistically significant difference in body mass index, age, high-density lipoprotein cholesterol and HbA1C between the three groups (P < 0.01 for all). Chi-square analysis revealed a statistically significant difference in diabetic retinopathy distribution (P < 0.01). None of these variables exhibited a statistically significant correlation with macular pigment optical density for any study group (P > 0.05 for all). There was no difference in dietary carotenoid intake between groups. Macular pigment optical density was lower among Type 2 diabetes subjects (0.33 ± 0.21) compared with Type 1 diabetes (0.49 ± 0.23) and controls (0.48 ± 0.35). General linear model analysis, including age, body mass index, diabetes duration, diabetic retinopathy status, high-density lipoprotein cholesterol, and HbA1C as covariates, revealed a statistically significant effect of diabetes type on macular pigment optical density (F = 2.62; P = 0.04). Macular pigment optical density was statistically significantly lower in Type 2 diabetes compared with Type 1 diabetes and normal controls. Although body mass index was higher in the Type 2 diabetes group, the lower macular pigment optical density levels observed among Type 2 diabetes seem not to be attributable to differences in dietary carotenoid intake or to the specific presence of diabetes, diabetic control, duration, or diabetic retinopathy.
Article
Full-text available
Background The macula (central retina) contains a yellow pigment, comprising the dietary carotenoids lutein (L), zeaxanthin (Z), and meso-zeaxanthin, known as macular pigment (MP). The concentrations of MP’s constituent carotenoids in retina and brain tissue correlate, and there is a biologically-plausible rationale, supported by emerging evidence, that MP’s constituent carotenoids are also important for cognitive function. Objective To investigate if patients with Alzheimer’s disease (AD) are comparable to controls in terms of MP and visual function. Methods 36 patients with moderate AD and 33 controls with the same age range participated. MP was measured using dual-wavelength autofluorescence (Heidelberg Spectralis®); cognitive function was assessed using a battery of cognition tests (including Cambridge Neuropsychological Test Automated Battery). Visual function was recorded by measuring best corrected visual acuity (BCVA) and contrast sensitivity (CS). Serum L and Z concentrations (by HPLC) and age-related macular degeneration (AMD, by retinal examination) status were also assessed. Results In the AD group, central MP (i.e., at 0.23°) and MP volume were significantly lower than the control group (p < 0.001 for both), as were measures of BCVA, CS, and serum L and Z concentrations (p < 0.05, for all). Conclusion AD patients were observed to exhibit significantly less MP, lower serum concentrations of L and Z, poorer vision, and a higher occurrence of AMD when compared to control subjects. A clinical trial in AD patients designed to investigate the impact of macular carotenoid supplementation with respect to MP, visual function, and cognitive function is merited.
Book
The first source to collect the latest evidence linking carotenoids to human health and disease, this stimulating reference studies the role of carotenoids in the prevention of chronic disease and reviews breakthrough studies from more than 40 field authorities on the latest research. The book reveals the most recent findings regarding the use of carotenoids in the prevention of cancers and sunburn, as well as eye, heart, vascular, and photosensitivity diseases, and evaluates the potential toxic effects of high-dose carotenoids in both smokers and drinkers. It also focuses on pioneering observations from observational epidemiological and clinical studies, as well as intervention trials on carotenoids.
Book
One of the most intriguing questions facing modern science is the inner workings of the human brain. Functional magnetic resonance imaging (fMRI) is a powerful tool used to study the human brain in action. The data produced from mapping the active processes within the brain present many challenges to statisticians, computer scientists, engineers and other data analysts, due to their complex structure and the ever-increasing sophistication of the scientific questions being posed by researchers. This book represents the first in-depth discussion of statistical methodology, which it couples with an introduction to the scientific background needed to understand the data. Starting from the basic science - where fMRI data come from, why they are so complicated, and the role statistics can play in designing and interpreting experiments - the book gives a detailed survey of the numerous methods that have been applied in the last fifteen years. The analysis of fMRI data features many of the major issues of concern in modern statistics, such as high dimensionality, multiple testing, and visualization. The array of techniques examined in the book ranges from the simple two-sample t-test and the general linear model to hierarchical spatiotemporal models, multivariate methods such as principal components analysis, and Bayesian approaches as they have been used in fMRI. Software, including descriptions of the most popular freeware packages and their capabilities, is also discussed. This book offers researchers who are interested in the analysis of fMRI data a detailed discussion from a statistical perspective that covers the entire process from data collection to the graphical presentation of results. The book is a valuable resource for statisticians who want to learn more about this growing field, and for neuroscientists who want to learn more about how their data can be analyzed. Nicole A. Lazar is Professor of Statistics at the University of Georgia and affiliated faculty of the Center for Health Statistics, University of Illinois at Chicago. She is a prominent researcher in this area, a contributor to the FIASCO software for fMRI data analysis, and heads an fMRI statistics research group at the University of Georgia.
Article
Purpose. Alteration of macular pigment optical density (MPOD) is a potential therapeutic approach to preventing retinal degenerative diseases. This study demonstrates that MPOD can be altered by adding carotenoid-rich foods to the diet. Methods. MPOD was measured psychophysically with a 1-deg stimulus. Plasma concentrations of lutein (L), zeaxanthin (Z), and beta-carotene (BC) were obtained by HPLC with a C30 column. Measurements of MPOD and plasma carotenoids were obtained for the following time periods: two baseline measurements; 4-wks; 8-wks; and 12-wks. At the time of the 2nd baseline measurement, 10 subjects added to their regular diets daily supplements of 60 g of spinach (11 mg L, 0.3 mg Z, 5 mg BC) and 150 g of corn (0.4 mg L, 0.3 mg Z); 1 subject was given only spinach and 2 subjects only corn; 3 subjects had missing data. Results. At 4-wks both MPOD (0.51 +/- 0.21) and plasma concentrations of L (35.0 +/- 14.7 μg/dL) increased significantly from baseline (MPOD = 0.43 +/- 0.17 and L = 20.5 +/- 8.4) (p<.02 and p<.001, respectively; matched pairs t test). At eight weeks, MPOD was not significantly different from baseline, but at 12 wks, MPOD was again elevated. Examination of individual records suggests three types of responses to dietary supplementation. 1) Nonresponders in both blood and retina. 2) Responders in blood but not retina. and 3) Responders in both blood and retina. Conclusions. The rapidity with which the retina responded to dietary modification was unexpected. Further, the magnitude of the response for some individuals was considerable (∼ 50%). Alteration of MPOD for both experimental study and therapeutic intervention may represent an important tool for future work.
Article
Observational data have suggested that high dietary intake of saturated fat and low intake of vegetables may be associated with increased risk of Alzheimer disease. To test the effects of oral supplementation with nutrients on cognitive function. In a double-masked randomized clinical trial (the Age-Related Eye Disease Study 2 [AREDS2]), retinal specialists in 82 US academic and community medical centers enrolled and observed participants who were at risk for developing late age-related macular degeneration (AMD) from October 2006 to December 2012. In addition to annual eye examinations, several validated cognitive function tests were administered via telephone by trained personnel at baseline and every 2 years during the 5-year study. Long-chain polyunsaturated fatty acids (LCPUFAs) (1 g) and/or lutein (10 mg)/zeaxanthin (2 mg) vs placebo were tested in a factorial design. All participants were also given varying combinations of vitamins C, E, beta carotene, and zinc. The main outcome was the yearly change in composite scores determined from a battery of cognitive function tests from baseline. The analyses, which were adjusted for baseline age, sex, race, history of hypertension, education, cognitive score, and depression score, evaluated the differences in the composite score between the treated vs untreated groups. The composite score provided an overall score for the battery, ranging from -22 to 17, with higher scores representing better function. A total of 89% (3741/4203) of AREDS2 participants consented to the ancillary cognitive function study and 93.6% (3501/3741) underwent cognitive function testing. The mean (SD) age of the participants was 72.7 (7.7) years and 57.5% were women. There were no statistically significant differences in change of scores for participants randomized to receive supplements vs those who were not. The yearly change in the composite cognitive function score was -0.19 (99% CI, -0.25 to -0.13) for participants randomized to receive LCPUFAs vs -0.18 (99% CI, -0.24 to -0.12) for those randomized to no LCPUFAs (difference in yearly change, -0.03 [99% CI, -0.20 to 0.13]; P = .63). Similarly, the yearly change in the composite cognitive function score was -0.18 (99% CI, -0.24 to -0.11) for participants randomized to receive lutein/zeaxanthin vs -0.19 (99% CI, -0.25 to -0.13) for those randomized to not receive lutein/zeaxanthin (difference in yearly change, 0.03 [99% CI, -0.14 to 0.19]; P = .66). Analyses were also conducted to assess for potential interactions between LCPUFAs and lutein/zeaxanthin and none were found to be significant. Among older persons with AMD, oral supplementation with LCPUFAs or lutein/zeaxanthin had no statistically significant effect on cognitive function. clinicaltrials.gov Identifier: NCT00345176.
Article
The relationship between lutein and zeaxanthin and visual and cognitive health throughout the lifespan is compelling. There is a variety of evidence to support a role for lutein and zeaxanthin in vision. Lutein's role in cognition has only recently been considered. Lutein and its isomer, zeaxanthin, are taken up selectively into eye tissue. Lutein is the predominant carotenoid in human brain tissue. Lutein and zeaxanthin in neural tissue may have biological effects that include antioxidation, anti-inflammation, and structural actions. In addition, lutein and zeaxanthin may be protective against eye disease because they absorb damaging blue light that enters the eye. In pediatric brains, the relative contribution of lutein to the total carotenoids is twice that found in adults, accounting for more than half the concentration of total carotenoids. The greater proportion of lutein in the pediatric brain suggests a need for lutein during neural development as well. In adults, higher lutein status is related to better cognitive performance, and lutein supplementation improves cognition. The evidence to date warrants further investigation into the role of lutein and zeaxanthin in visual and cognitive health throughout the lifespan.